Eloctate

This page shows the latest Eloctate news and features for those working in and with pharma, biotech and healthcare.

Roche gets wider approval for haemophilia drug Hemlibra

Adynovate, Biogen’s Eloctate, Bayer’s Kovaltry and CSL Behring’s Afstyla – with the advantage of being dosed every one, two, or four weeks depending on need, rather than multiple times

Latest news

Bayer roll-out of haemophilia drug Jivi gathers pace

and Eloctate, and CSL Behring’s Afstyla, uptake hasn’t been as quick as many had hoped, so Jivi is entering a challenging market.
Roche highlights Hemlibra data as key FDA date approaches

every few days, such as Shire’s Adynovate, Biogen’s Eloctate, Bayer’s Kovaltry and CSL Behring’s Afstyla, uptake hasn’t been as quick as hoped.
Roche’s Hemlibra first drug to top standard therapy in haemophilia A

well as Biogen’s Eloctate, Bayer’s Kovaltry and CSLBehring’s Afstyla.
Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

Bioverativ separated from Biogen last year to create a stand-alone haemophilia specialist with two marketed drugs - Eloctate (efmoroctocog alfa) and Alprolix (eftrenonacog alfa) which brought in sales estimated to be ... longer acting therapies such as
New data could unlock bigger market for Roche’s Hemlibra

Haemophilia A treatment is being transformed by a series of long-acting Factor VIII products such as Biogen’s Eloctate, Shire’s Adynovate, Bayer’s Kovaltry and CSLBehring’s Afstyla, which

More from news
Approximately 3 fully matching, plus 23 partially matching documents found.

Latest Intelligence

Deal Watch January 2018

Paying $105 per share in cash (64% premium over Bioverativ’s closing price on 19 January), Sanofi gains the marketed products, Eloctate (haemophilia A therapy) and Alprolix (haemophilia B therapy), as ... During 2016 Eloctate and Alprolix generated

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager / Senior Account Manager: 35, 000-40, 000

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Senior Systematic Review Analyst - Oxford: Negotiable

Scientific Director / Editorial Team Leader: Great salary and benefits

Account Director: £48, 000 - £60, 000

Account Director: Excellent benefits

Associate Medical Director: Highly Competitive

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Senior Medical Writer: Great salary and benefits

Senior Account Executive, London, Medical Communications: Excellent package

Medical Writers: Competitive Salary and Benefits

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Project / Account Manager (Medical Education): Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Consultant Health Economics - London / Oxford: Negotiable

Medical/ Scientific Director: Salary TBC

New Business Director - PR: Competitive Salary and benefits

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Events Manager – Med Comms – Surrey: Salary TBC

Associate Editorial Director – Med Comms – London: Salary TBC

Senior Medical Writer (Remote Working): Competitive Salary Offered

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...